mercredi 7 février 2018
  0 Réponses
  5.6K Visites

PATH’s Freeze-Safe innovation sets a new benchmark, helping protect vaccine potency, reducing health worker burden, and providing cost savings to health systems

Seattle, February 7, 2018—This week, the first commercially available freeze-free vaccine carrier will begin introductory field trials in Nepal. This follows the World Health Organization (WHO) announcement that the Indian-made carrier using PATH’s “Freeze-Safe” reference design passed WHO Performance, Quality, and Safety (PQS) laboratory tests for User Independent Freeze Prevention, which prequalifies it for use in global immunization programs. This is the first low-cost carrier innovation available to address the widespread and long-standing problem of vaccines freezing in the cold chain during the “last mile” of outreach to infants and children.
[Read more]

Freeze-preventive carrier

 

Media inquiries:

Il n'y a pas encore de réponse à ce message.